Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Kawanaka H et al. – This report describes the use of controlled–release basic fibroblast growth factor for an ischemic leg ulcer in a patient with CSS, suggesting a possible therapeutic role of this novel neovascularization therapy in treating severe skin lesions complicating autoimmune vasculitis syndromes.

   

Related Articles

Exploring the complex care of the diabetic foot ulcer
JAAPA, 10/30/09    Relevance Score: 71%

Effectiveness of insoles used for the prevention of ulceration in the neuropathic diabetic foot: a systematic review
Journal of Diabetes and its Complications, 10/29/09    Relevance Score: 68%

Digital ulcers as the first manifestation of carpal tunnel syndrome
Rheumatology International, 11/17/09    Relevance Score: 67%

Oxidative Stress Markers Regulating the Healing of Foot Ulcers in Patients With Type 2 Diabetes Diabetes
Wounds, 10/28/09    Relevance Score: 67%

Churg-Strauss syndrome successfully treated with rituximab
Rheumatology International, 10/15/09    Relevance Score: 67%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address